BioNTech SE (BNTX) Invested Capital (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Invested Capital data on file, last reported at $409.4 million in Q4 2025.

• In Q4 2025, Invested Capital changed N/A year-over-year to $409.4 million; the TTM figure through Dec 2025 stood at $1.7 billion (up 195.58% YoY), while the FY2025 annual figure was $397.4 million, changed N/A from the prior year.
• Invested Capital eased to $409.4 million in Q4 2025, from $698.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $15.5 billion in Q4 2021 and bottomed at $6.2 million in Q4 2022.
• A 5-year average of $2.0 billion and a median of $373.6 million in 2021 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital sank 99.96% — and 2023, when it surged 838.43%.
• Year by year, Invested Capital stood at $15.5 billion in 2021, then slumped by 99.96% to $6.2 million in 2022, then soared by 5525.29% to $350.1 million in 2023, then dropped by 24.21% to $265.3 million in 2024, then surged by 54.3% to $409.4 million in 2025.
• The last three Invested Capital figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.

Peer Comparison